A Tri-specific antibody therapeutic consisting of an anti-IL-17 A/F Fragment antigen binding (Fab) with an anti-TNF single chain fragment variable (scFv) attached to the the light chain and an anti-albumin scFv attached to the heavy chain by G4S linker's.